Get startedLog in
    Picture of Kiniksa Pharmaceuticals International logo

    KNSA — Kiniksa Pharmaceuticals International News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Kiniksa Pharmaceuticals Files Prospectus Relates To Proposed Resale Of 28,682,554 Class A Common Shares Offered By Selling Shareholders - SEC Filing

    Picture of Kiniksa Pharmaceuticals International logoKiniksa Pharmaceuticals International
    06/05/2022 21:15
    May 6 (Reuters) - Kiniksa Pharmaceuticals Ltd  KNSA.O :
    * KINIKSA PHARMACEUTICALS FILES PROSPECTUS RELATES TO
PROPOSED
RESALE OF 28,682,554 CLASS A COMMON SHARES OFFERED BY SELLING
SHAREHOLDERS - SEC FILING

Source text: [ID: https://bit.ly/3LOoyHY]
Further company coverage:  KNSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Kiniksa Pharmaceuticals International

    See all news